The price of AMN Healthcare Services Inc. (NYSE: AMN) closed at $85.15 in the last session, down -0.19% from day before closing price of $85.31. In other words, the price has decreased by -$0.16 from its previous closing price. On the day, 584201 shares were traded. AMN stock price reached its highest trading level at $85.28 during the session, while it also had its lowest trading level at $83.71.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
We take a closer look at AMN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 55.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.21. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.30. In the meantime, Its Debt-to-Equity ratio is 0.81 whereas as Long-Term Debt/Eq ratio is at 0.81.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on October 08, 2020, initiated with a Buy rating and assigned the stock a target price of $70.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 09 when Jackson Denise L sold 4,001 shares for $110.76 per share. The transaction valued at 443,151 led to the insider holds 14,078 shares of the business.
Jackson Denise L sold 1,002 shares of AMN for $109,519 on Jan 06. The Chief Legal Officer now owns 18,079 shares after completing the transaction at $109.30 per share. On Nov 07, another insider, WHEAT DOUGLAS D, who serves as the Director of the company, sold 4,900 shares for $118.00 each. As a result, the insider received 578,200 and left with 65 shares of the company.
As of this moment, AMN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.65, and their Forward P/E ratio for the next fiscal year is 10.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.45. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68 while its Price-to-Book (P/B) ratio in mrq is 3.52.
Stock Price History:
Over the past 52 weeks, AMN has reached a high of $129.04, while it has fallen to a 52-week low of $82.75. The 50-Day Moving Average of the stock is 96.67, while the 200-Day Moving Average is calculated to be 107.27.
According to the various share statistics, AMN traded on average about 826.77K shares per day over the past 3-months and 720.09k shares per day over the past 10 days. A total of 43.20M shares are outstanding, with a floating share count of 40.80M. Shares short for AMN as of Jan 30, 2023 were 4.84M with a Short Ratio of 5.89M, compared to 4.63M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 11.17% and a Short% of Float of 16.01%.
The company has 9 analysts who recommend its stock at the moment. On average, analysts expect EPS of $2.14 for the current quarter, with a high estimate of $2.26 and a low estimate of $1.75, while EPS last year was $2.95. The consensus estimate for the next quarter is $2.08, with high estimates of $2.24 and low estimates of $1.78.
Analysts are recommending an EPS of between $11.69 and $11.45 for the fiscal current year, implying an average EPS of $11.59. EPS for the following year is $8.47, with 9 analysts recommending between $8.96 and $7.29.
According to 8 analysts, the current quarter’s revenue is expected to be $1.07B. It ranges from a high estimate of $1.08B to a low estimate of $1.06B. As of the current estimate, AMN Healthcare Services Inc.’s year-ago sales were $1.36B, an estimated decrease of -21.70% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $1.07B, a decrease of -30.80% less than the figure of -$21.70% in the same quarter last year. There is a high estimate of $1.09B for the next quarter, whereas the lowest estimate is $1.05B.
A total of 8 analysts have provided revenue estimates for AMN’s current fiscal year. The highest revenue estimate was $5.2B, while the lowest revenue estimate was $5.18B, resulting in an average revenue estimate of $5.19B. In the same quarter a year ago, actual revenue was $3.98B, up 30.10% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $4.26B in the next fiscal year. The high estimate is $4.32B and the low estimate is $4.18B. The average revenue growth estimate for next year is down -17.90% from the average revenue estimate for this year.